Stelara 90MG/ML SYR 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTLY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $99,505
Award facts
- Contract value 100% obligated
- $99,504.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $99,504.78 to DMS Pharmaceutical Group Inc. for Stelara 90mg/ml syrup on January 14, 2026, with an ultimate completion date of February 4, 2026. This firm fixed-price delivery order was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing a comprehensive range of pharmaceutical products and medical consumables to Department of Defense facilities.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. Awarded on November 13, 2025, the IDC carries a $500 million ceiling and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V contract positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors under the broader $30.3 billion acquisition strategy designed to provide the Department of Defense with diverse pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FBTLY?
SPE2DR26FBTLY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FBTLY worth?
The government has obligated $99,505 on SPE2DR26FBTLY.
Is contract SPE2DR26FBTLY an order under another contract?
Yes. SPE2DR26FBTLY is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTLY competed?
The extent of competition for SPE2DR26FBTLY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award